Back

Plasma levels of amyloid beta 1-40 are associated with ultrasonographic morphological characteristics related with carotid plaque vulnerability in individuals without cardiovascular disease

27 August 2023 (10:15 - 10:45)
Organised by: Logo
Congress Presentation Part of: Cardiovascular risk assessment: biomarkers Biomarkers ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Dimitrios Delialis

Alexandra University Hospital, Athens (Greece)

3 More presentations in this session

Presentation thumbnail
The association of lipoprotein(a) with patient characteristics and mortality in a primary prevention cohort: data from our clinic database
Doctor L. Cho (Cleveland, US)
Abstract Slides Video
Presentation thumbnail
Plasma proteomics identify fibroblast growth factor 5 as a biomarker for genetically proven Familial Hypercholesterolemia
Doctor A. Baragetti (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Association of random glucose to albumin ratio with post-contrast acute kidney injury and clinical outcomes in patients with ST-elevation myocardial infarction
Mr Y. Liu (Guangzhou, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular risk assessment: biomarkers

The Event

Event poster

ESC Congress 2023

27 August 2023 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Circulating Amyloid beta 1-40 is independently associated with statin treatment and LDL cholesterol reduction: a prospective cohort study
thumbnail
Congress Presentation
Circulating levels of amyloid-beta (1-40) peptide associate with cardiometabolic traits and risk for metabolic dysfunction-associated steatotic liver disease
thumbnail
Congress Presentation
Incremented Amyloid-beta values predict mortality during long-term follow-up in patients with acute myocardial infarction, both STEMI and NSTEMI

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources